๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Treatment of relapsed or refractory acute promyelocytic leukemia

โœ Scribed by Martin S. Tallman

Book ID
119195362
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
128 KB
Volume
20
Category
Article
ISSN
1521-6926

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Mitoxantrone in relapsed or refractory a
Mitoxantrone in relapsed or refractory acute nonlymphocytic leukemia
โœ Vredenburgh, James J. ;McLntyre, O. Ross ;Cornwell, Gibbons G. ;Ball, Edward D. ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 266 KB

Seventeen patients with relapsed or refractory acute nonlymphocytic leukemia were treated with 14 mg/m2 of mitoxantrone given in a 30-minute infusion daily for three days. If the day fourteen bone marrow showed residual leukemia, a second course was given at the same dose for two days. Eight patient

All-trans retinoic acid followed by chem
All-trans retinoic acid followed by chemotherapy for salvage of refractory or relapsed acute promyelocytic leukemia
โœ Jorge E. Cortes; Hagop Kantarjian; Susan O'Brien; L. E. Robertson; Charles Kolle ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 599 KB

Background. All-trans retinoic acid (ATRA) is effective in the treatment of relapsed or refractory acute promyelocytic leukemia (APL), but relapse is the rule if response is unmaintained. Methods. Seventeen patients with APL were salvaged with ATRA at a dosage of 50 mg/mz/day for 3 months or until